Prelude Capital Management, LLC Gilead Sciences, Inc. Put Options Transaction History

Prelude Capital Management, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $1 Million - $1.1 Million	16,300 New	16,300 $1.06 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $2.5 Million - $2.76 Million	-40,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $618,700 - $693,800	-10,000 Reduced 20.0%	40,000 $2.7 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $625,300 - $700,500	10,000 Added 25.0%	50,000 $3.25 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $302,700 - $395,000	5,000 Added 14.29%	40,000 $2.5 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $2.27 Million - $2.65 Million	35,000 New	35,000 $2.48 Million

1,926

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.